Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MeReC Rapid Review Launched

The National Prescribing Centre has launched a new category of MeReC publications. As detailed in MeReC Extra 22 the Rapid Reviews will only be available online.

Readers can register to receive an email notification when new Rapid Reviews are published.

The topic of the first Rapid Review is the results of the ESPRIT Study. This study was prospective and randomised by design and examined the primary composite outcome of death from all vascular causes, non-fatal stroke, non-fatal myocardial infarction (MI), or major bleeding complications. Patients were randomised to aspirin (30-325mg daily, mean 75mg) with or without dipyridamole (200mg twice daily).

The result was that significantly fewer patients in the dipyridamole arm had a primary outcome event compared to those in the aspirin only arm. This finding supports the recommendations in the NICE Guidance on Vascular Disease - Clopidogrel and dipyridamole.

Action: Rapid Reviews promise to be a useful tool to aid prescribing decisions. Clinicians are encouraged to subscribe to the email notifications.

Share 'MeReC Rapid Review Launched' on Email Share 'MeReC Rapid Review Launched' on Delicious Share 'MeReC Rapid Review Launched' on Digg Share 'MeReC Rapid Review Launched' on Facebook Share 'MeReC Rapid Review Launched' on Google+ Share 'MeReC Rapid Review Launched' on reddit Share 'MeReC Rapid Review Launched' on StumbleUpon Share 'MeReC Rapid Review Launched' on Twitter

atomic-wealth

No Comments to “MeReC Rapid Review Launched”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,657 spam comments.

atomic-wealth
fond-illness
summer